Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Contrast-Induced Nephropathy

Have you ever thought about the risks that contrast media in medical imaging tests present? In this guide we examine how contrast-induced nephropathy (CIN) affects kidney health. Read this blog post to learn about CIN risk factors and symptoms along with essential management precautions for this rare condition.

What is Contrast-Induced Nephropathy (CIN)?

Contrast-induced nephropathy (CIN) represents kidney damage which arises after contrast media administration during diagnostic imaging procedures including angiograms and CT scans. During imaging procedures the toxic properties of contrast dye can lead to kidney damage particularly in patients who already have kidney issues or other risk factors. Patients who have kidney disease and also suffer from diabetes, dehydration or heart disease combined with repeated exposure to contrast media face greater chances of developing contrast-induced nephropathy throughout their lives.

Symptoms and Risk Factors

Contrast-induced nephropathy becomes more likely in patients with poor kidney function who also have diabetes and dehydration and those who experience heart disease or frequent contrast media exposure along with older adults. Reduced urine production and increased serum creatinine concentrations emerge as usual symptoms for contrast-induced nephropathy within 24 to 48 hours after receiving contrast dye.

Management and Prevention

The management of contrast-induced nephropathy is confined to supportive care after onset yet preventing this condition requires essential implementation of strategic measures. Patients with kidney issues should keep proper hydration levels before and after imaging tests to reduce the risk of developing contrast-induced nephropathy. When treating patients with existing kidney risk factors healthcare providers must determine if contrast media is necessary for imaging procedures.

Preventive Measures

  1. Stay Hydrated: Patients should drink enough water before and after imaging tests to keep their kidney function adequate.
  2. Monitor Kidney Health: People with existing kidney disease or diabetes should monitor their kidney health through routine checks.
  3. Communicate with Healthcare Providers: Before receiving imaging tests patients must inform their healthcare providers about their existing health problems and potential kidney damage risk factors.
  4. Limit Contrast Media Exposure: Individuals with past kidney issues need to avoid unnecessary exposure to contrast media.

Knowing the risks of contrast-induced nephropathy helps maintain kidney health and general well-being. Taking preventive measures against CIN and preserving kidney function helps people minimize the risk of complications from contrast media during imaging tests. PlexusDx Precision Health & Wellness tests enable patients to identify genetic predispositions which help guide informed health decisions. You can safeguard your kidney health by educating yourself about prevention and taking immediate steps.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves